BioCentury on BioBusiness,
Emerging Company Profile
SMC Biotech enhancing bone healing without increasing bone growth factor
Related tables, figures and sidebars
SMC: Sweet science for bones
Monday, October 14, 2013
Biotechnology Inc. is developing a carbohydrate that promotes bone
healing by enhancing the regenerative effects of bone morphogenetic protein 2,
without actually increasing levels of the growth factor. The company expects
its approach will avoid safety issues associated with a marketed recombinant
BMP2 promotes bone growth by inducing osteoblast
Inc.'s InFuse Bone graft is an implantable product that delivers
recombinant BMP2. InFuse has FDA clearance for use in orthopedic indications,
but its clinical utility remains controversial, according to SMC President and
CEO Michael Crockett, who said the main issue is the possible risk of
words displayed of
To read this article, you must be an Archives subscriber. Please choose one of the options below.
All contents Copyright © 1993-2016 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Whether you want an individual subscription or need a global group license, we have the products,
the experience and the customer support that biopharma executives, researchers, investors, service providers,
and industry stakeholders have trusted for nearly two decades.
Let our Subscriber Services team customize the best intelligence package available in the industry to meet your needs.
Free Trial Subscription 4 Weeks of Access
BioCentury's Weekly Business Intelligence Journal
Get a 4-week free trial subscription to BioCentury.
Get 4 Weeks Free
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]